ChemicalBook > Product Catalog >API >Circulatory system drugs >Antihypertensive drugs >Candesartan

Candesartan

Candesartan Structure
CAS No.
139481-59-7
Chemical Name:
Candesartan
Synonyms
Atacend;CV-11974;CILEXITIL;CANDESARTAN;tandishatan;Candesartan M1;Candesartan 98%;Candesartan Base;Candesartan (C8);Candesartan (Atacand)
CBNumber:
CB0209324
Molecular Formula:
C24H20N6O3
Molecular Weight:
440.45
MOL File:
139481-59-7.mol
Modify Date:
2024/5/10 17:26:08

Candesartan Properties

Melting point 183-185°C
Boiling point 754.8±70.0 °C(Predicted)
Density 1.41±0.1 g/cm3(Predicted)
RTECS DD6671000
storage temp. Inert atmosphere,Store in freezer, under -20°C
solubility Soluble in DMSO (up to 40 mg/ml)
form solid
pka 2.06±0.10(Predicted)
color White
Water Solubility Soluble in ethyl acetate, methanol, water (<1 mg/ml at 25°C), DMSO (88 mg/ml at 25°C), and ethanol (1 mg/ml at 25°C).
Stability Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 2 months.
CAS DataBase Reference 139481-59-7(CAS DataBase Reference)

SAFETY

Risk and Safety Statements

Symbol(GHS) 
GHS07
Signal word  Warning
Hazard statements  H302-H312-H315-H319-H332-H335
Precautionary statements  P261-P280-P304+P340-P305+P351+P338-P405-P501a
Hazard Codes  Xn
Risk Statements  20/21/22-36/37/38
Safety Statements  26-36-60-36/37-9
HS Code  29419000

Candesartan Chemical Properties,Uses,Production

Chemical Properties

Crystalline Solid

Uses

Candesartan is a selective AT1 (angiotensin II receptor 1) antagonist. Antagonism of angiotensin receptors inhibits vasoconstriction and the production of aldosterone, leading to a decrease in water and sodium concentration in blood plasma. Exhibits antihypertensive effects in animal models. Used in treatment of congestive heart failure, as antihypertensive. Candesartan does not affect cell viability or proliferation but increases the expression of VEGF and interleukin-8 in the cultured medium of KU-19-19 cells. Candesartan (0.1 nM) could reduce the maximal contractile response to angiostensin II by approximately 50%.

Definition

ChEBI: A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin eceptor antagonist used for the treatment of hypertension.

General Description

Candesartan, (+)-1-[[(cyclohexyloxy)carbonyl]-oxy]ethyl 2- ethoxy-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylate(Atacand), like losartan, possesses the acidic tetrazole system,which most likely plays a role in binding to the angiotensin IIreceptor similarly to the acidic groups of angiotensin II. Also,the imidazole system has been replaced with a benzimidazolepossessing an ester at position. This ester must be hydrolyzedto the free acid. Fortunately, this conversion takesplace fairly easily because of the carbonate in the ester sidechain. This facilitates hydrolysis of the ester so much thatconversion to the free acid takes place during absorption fromthe gastrointestinal tract.

Candesartan Preparation Products And Raw materials

Global( 498)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
ALMELO PRIVATE LIMITED +91-9100991345 +91-8500807769 Telangana, India 114 58 Inquiry
Chemicea Pharmaceuticals Pvt Ltd +91-918482849343 +91-8482849343 Mumbai, India 461 58 Inquiry
CLEANCHEM LABORATORIES LLP +91-9951015911 +91-9951015911 Mumbai, India 281 58 Inquiry
GLP Pharma Standards +91 9866074638 Hyderabad, India 1644 58 Inquiry
CHEMAZON LABORATORIES +91 9848551964 Hyderabad, India 1320 58 Inquiry
Lupin Ltd +91-8019896181 +91-8019896181 Maharashtra, India 93 58 Inquiry
Lakshmi Farmachem +91-9948795885 +91-9550886476 Telangana, India 407 58 Inquiry
Gensynth Laboratories Pvt. Ltd +91-9502663206 +91-9502663206 Hyderabad, India 22 58 Inquiry
Besil Chem LLP +91-7760252666 +91-9880731835 Bangalore, India 163 58 Inquiry
Lavybens Pharma +91-8790466757 +91-8790466756 Telangana, India 80 58 Inquiry

Candesartan Spectrum

1-((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)Methyl)-2-ethoxy-1H-benzo[d]iMidazole-7-carboxylic acid 2-ethoxy-3-[[4-[2-(1h-tetrazol-5-yl)phenyl]phenyl]methyl]-3h-benzoimidazole-4-carboxylic acid 3-[[2'-(1H-Tetrazol-5-yl)biphenyl-4-yl]Methyl]-2-ethoxy-3H-benziMidazole-4- carboxylic Acid Candesartan M1 2-ETHOXY1-2(1H-TETRAZOL-5YL)1,1-BIPHENYL)-4-YL)-4-YL)METHYL)1H-BENZIMIDAZOLE-7-CARBOXYLIC ACID Candesartan Cilexetil EP IMpurity G 1-((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylic 1H-Benzimidazole-7-carboxylic acid, 2-ethoxy-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- 1-((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxy Candesartan Base 2-ETHOXY-1-[[2'-(1H-TETRAZOL-5-YL)(1,1'-BIPHENYL)-4-YL]METHYL]-1H-BENZIMIDAZOLE-7-CARBOXYLIC ACID Candesartan[CandesartanCilexetilIntermediates] Candesartan ( For Candesartan Cilexetil ) CANDESARTAN CV-11974 CILEXITIL 2-Ethoxy-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic Acid, CV-11974 2-Ethoxy-1-[2'-(1-triphenylmethyltetrazol-5-yl)-biphenyl-4-yl-methyl]benzimidazole-7-carboxylicacidcyclohexyl-1-chloroethylcarbonate 2-ethoxy-1-[[(2-(1Htetrazol-5-yl)biphenyl-4-yl-) methyl] 2-Ethoxy-3-[[4-[2-(1H-tetrazol-5-yl)phenyl]phenyl] Atacend 2-Ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazol-7-carboxylic acid (±)-2-Ethoxy-1-[[2’-(1H-tetrazol-5-y1)[1,l'-biphenyl]-4-y1]methyl]-1H-benzimidazole-7-earboxylic acid 3-(2'-Cyano-biphenyl-4-ylMethyl)-2-ethoxy-3H-benzoiMidazole-4-carboxylic acid Me 2-ethoxy-1-({4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}Methyl)-1H-1,3-benzodiazole-7-carboxylic acid Candesartan (Atacand) Candesartan 98% Candesartan (Candesartan Cilexetil impurity G) Candesartan Solution, 1000ppm Candesartan Cilexetil Impurity 7(EP Impurity G) Candesartan Solution, 100ppm tandishatan Candesartan Cilexetil EP Impurity G(Candesartan) 2-Ethoxy-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid 2-Ethoxy-1-[[(2′-(1Htetrazol-5-Yl)Biphenyl-4-Yl-) Methyl]Benzimidazole-7-Carboxylic Acid Candesartan (C8) 1-((2'-(2H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylic acid Candesartan USP/EP/BP Cesartan intermediates Candesartan EP Impurity G Candesartan Cilexetil EP Impurity G (Candesartan Acid) Candesartan Impurity -G Candesartan Cilexetil EP Impurity G High Quality Intermediates Candesartan CAS: 139481-59-7 Candesartan (CV 11974) candesartan cilexetil impurity1364 CandesartanQ: What is Candesartan Q: What is the CAS Number of Candesartan Q: What is the storage condition of Candesartan Q: What are the applications of Candesartan Candesartan Cilexetil Related Compound G (1-{[2''-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-2-ethoxybe (1087870) Candesartan Cilexetil USP Related Compound G Candesartan Cilexetil Impurity 7(Candesartan Cilexetil EP Impurity G) 3-((2'-(2H-Tetrazol-5-yl)biphenyl-4-yl)methyl)-2-ethoxy-3H-benzo[d]imidazole-4-carboxylic acid [CS-VII (Acid) Candesartan Impurity-G 1-((2'-(2H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylic acid 1-((2'-(1H-Tetrazol-5-yl)-[1,1'-Biphenyl]-4-yl)Methyl)-2-Ethoxy-1H-Benzo[d]iMidazole-7-Carboxylicacid 139481-59-7 C24H20N6O3 Isotope Pharmaceutical raw material Aromatics